CClinicalTrials.gg
CompletedNCT03119376Updated Sep 11, 2018

Web-based Tool to Improve the Assessment of Reporting (COBPeer)

An interventional study of COBPEER in Peer Review, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-09-11.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The peer review process is a cornerstone of biomedical research publication. Despite being essential, the assessment of the completeness of the reporting and the identification of switched outcomes are not appropriately performed. Furthermore, these tasks do not suppose a high level of expertise and could be performed by junior researchers.

To assess the completeness of reporting and identified switched outcome(s), junior peer reviewers could use a simple online tool (COBPeer) based on the CONSORT (Consolidated Standards of Reporting Trials) 2010 checklist and Elaboration and Explanation publication for reporting parallel-group RCTs. The tool would feature bullet points eliciting the meaning of each checklist item. The aim of this study that will compare the accuracy of junior peer reviewers using the tool to that of usual peer reviewers when evaluating the completeness of reporting and switched of primary outcome(s) in reports of RCTs

Read the detailed description

BACKGROUND: Context Inadequate reporting is a frequent cause of waste of research. To overcome this issue, the CONSORT statement, an evidence-based, minimum set of recommendations for reporting RCTs was developed in 1996. These guidelines have since been updated in 2001 and more recently in 2010. Many journals endorse the CONSORT statement. Some journals provide recommendations to authors to follow the CONSORT guidelines and some editors enforce the use of the CONSORT guidelines by requesting authors to submit a checklist in either the submission or acceptance stage. Nevertheless, inadequate reporting remains.

HYPOTHESE: To assess the completeness of reporting, junior peer reviewers could use a simple online tool based on the CONSORT 2010 checklist and Elaboration and Explanation publication for reporting parallel-group RCT

OBJECTIVE: 1) Develop an online tool and training module dedicated to junior peer reviewers for a) assessing the completeness of reporting of key items and b) identifying switched primary outcome(s) in reports of RCTs. 2) Compare the performance of junior peer reviewers using this tool with the usual peer-review process in identifying inadequate reporting and switched primary outcome(s) in reports of RCTs.

STUDY DESIGN: randomized ratio 1:1 controlled trial with two parallel arms. Participants will be invited to participate by invitation.

ELIGIBILITY: eligible participants are juniors peer reviewers. Junior peer reviewers are defined as early stage researchers: master students, PhD students, residents involved in clinical research during their study, and clinicians who have never reviewed a manuscript

INTERVENTION: the peer-review tool will be based on 10 items of the CONSORT Statement. This tool reminds the peer reviewer of the CONSORT item which must be reported by explicating it with a series of questions. The training module will explain each item to be evaluated with examples followed by a series of exercises from published randomized trial extracts.

MANUSCRIPT SELECTION: sample of randomized controlled trials published by Annals of Emergency Medicine, British Medical Journal, British Medical Journal Open and BioMed Central series medical.

EVALUATION BY THE JUNIOR PEER REVIEWERS: the junior peer reviewer who has accepted to participate and who has passed the training with success, will have to evaluate 1 article of the selected randomized sample.

EVALUATION OF THE USUAL PEER REVIEWERS: the evaluation by the usual peer-reviewers will be obtained by an analysis of the comments of the peer-reviewers which are available on line or obtained from the publisher.

GOLD STANDARD: peers of researchers who are experts in conducting systematic reviews will evaluate each article independently from other evaluations. Disagreements will be resolved by consensus.

PRIMARY OUTCOME: the mean number of items accurately classified per manuscript

SECONDARY OUTCOMES: the mean number of items accurately classified per manuscript for the 10 CONSORT items; the sensitivity, specificity and likelihood ratio to detect the item as adequately reported and to identify switch in primary outcome(s).

SAMPLE SIZE: 120 manuscripts and 120 peer reviewers juniors.

02

Conditions studied

  • Peer Review

Keywords

  • peer review
  • online tool
  • Randomized Controlled Trial
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • master students,
  • PhD students,
  • residents involved in clinical research during their study,
  • clinicians who have never reviewed a manuscript

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (actual)

Study arms

  • No intervention
    USUAL PEER REVIEWER

    Two researchers will read all the peer-review reports and editors' comments for the first round. The researchers will determine whether the peer-reviewers and/or editors raised some concern on the completeness of reporting of the 10 CONSORT items considered and identified a switch primary outcome(s) between the manuscript and the register. The assessment of all peer-review reports and editors' comments for each manuscript will be combined (i.e., the item will be rated as incompletely reported if at least one peer reviewer rated it as such). The 2 researchers will be blinded to the gold standard assessment.

  • Experimental
    COBPeer

    Junior peer reviewers will be invited to participate in an online training course on peer review (COBPeer).

    Other: COBPEER

  • No intervention
    GOLD STANDARD

    Pairs of systematic reviewers will independently extract data from eligible reports. Reviewers involved in the data extraction will have expertise in the conduct of systematic reviews and will assess the completeness of reporting from the systematic reviewer perspective. They will not have access to the tool to avoid being influenced by the tool. The systematic reviewers will also systematically compare the primary outcome(s) reported in the manuscript and the primary outcome(s) reported in the registry and will document any discrepancies.

Interventions

  • OtherCOBPEER

    At the end of the online training, they can participate in the study and so peer review 1 manuscript randomly selected from our sample with our tool (COBPeer).

06

What researchers measure

Primary outcomes

  1. the mean number of items accurately classified per manuscript

    Each item will be classified as"adequately reported" (yes/no)

    Time frame: through study completion, an average of 6 month

Secondary outcomes

  1. the mean number of items accurately classified per manuscript for the 10 CONSORT items

    Each item will be classified as"adequately reported" (yes/no)

    Time frame: through study completion, an average of 6 month

  2. the sensitivity, specificity and likelihood ratio to detect the item as adequately reported and to identify switch in primary outcome(s).

    test for pair proportion

    Time frame: through study completion, an average of 6 month

07

Study locations

1 site
  • Hotel Dieu, 1, place du parvis de notre dame
    Paris, 75004, France
08

References and documents

Publications

  • Chauvin A, Ravaud P, Moher D, Schriger D, Hopewell S, Shanahan D, Alam S, Baron G, Regnaux JP, Crequit P, Martinez V, Riveros C, Le Cleach L, Recchioni A, Altman DG, Boutron I. Accuracy in detecting inadequate research reporting by early career peer reviewers using an online CONSORT-based peer-review tool (COBPeer) versus the usual peer-review process: a cross-sectional diagnostic study. BMC Med. 2019 Nov 19;17(1):205. doi: 10.1186/s12916-019-1436-0. PubMed 31744489 ↗
  • Chauvin A, Moher D, Altman D, Schriger DL, Alam S, Hopewell S, Shanahan DR, Recchioni A, Ravaud P, Boutron I. A protocol of a cross-sectional study evaluating an online tool for early career peer reviewers assessing reports of randomised controlled trials. BMJ Open. 2017 Sep 15;7(9):e017462. doi: 10.1136/bmjopen-2017-017462. PubMed 28918414 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03119376
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
University of Oxford, University of Ottawa, University of California, Los Angeles
Responsible party
Isabelle BOUTRON (Professor, Assistance Publique - Hôpitaux de Paris) — Principal investigator
First posted
Apr 18, 2017
Start date
Dec 10, 2017
Primary completion
Jan 20, 2018
Completion
Jan 20, 2018
Last update
Sep 11, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion